Global Herceptin Biosimilar Market Professional Survey Report 2017
- QYR2276490
- 107 Pages
- December 2017
- Pharmaceuticals
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Mylan
Amgen
Mabion
AryoGen Biopharma
Genor Biopharma
The Instituto Vital Brazil
Celltrion
Gedeon Richter
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Capsule
Tablet
Others
By Application, the market can be split into
Healthcare&Pharmaceuticals
Others
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Herceptin Biosimilar Market Professional Survey Report 2017
1 Industry Overview of Herceptin Biosimilar
1.1 Definition and Specifications of Herceptin Biosimilar
1.1.1 Definition of Herceptin Biosimilar
1.1.2 Specifications of Herceptin Biosimilar
1.2 Classification of Herceptin Biosimilar
1.2.1 Capsule
1.2.2 Tablet
1.2.3 Others
1.3 Applications of Herceptin Biosimilar
1.3.1 Healthcare&Pharmaceuticals
1.3.2 Others
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Herceptin Biosimilar
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Herceptin Biosimilar
2.3 Manufacturing Process Analysis of Herceptin Biosimilar
2.4 Industry Chain Structure of Herceptin Biosimilar
3 Technical Data and Manufacturing Plants Analysis of Herceptin Biosimilar
3.1 Capacity and Commercial Production Date of Global Herceptin Biosimilar Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Herceptin Biosimilar Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Herceptin Biosimilar Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Herceptin Biosimilar Major Manufacturers in 2016
4 Global Herceptin Biosimilar Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Herceptin Biosimilar Capacity and Growth Rate Analysis
4.2.2 2016 Herceptin Biosimilar Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Herceptin Biosimilar Sales and Growth Rate Analysis
4.3.2 2016 Herceptin Biosimilar Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Herceptin Biosimilar Sales Price
4.4.2 2016 Herceptin Biosimilar Sales Price Analysis (Company Segment)
5 Herceptin Biosimilar Regional Market Analysis
5.1 North America Herceptin Biosimilar Market Analysis
5.1.1 North America Herceptin Biosimilar Market Overview
5.1.2 North America 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.1.4 North America 2016 Herceptin Biosimilar Market Share Analysis
5.2 China Herceptin Biosimilar Market Analysis
5.2.1 China Herceptin Biosimilar Market Overview
5.2.2 China 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.2.4 China 2016 Herceptin Biosimilar Market Share Analysis
5.3 Europe Herceptin Biosimilar Market Analysis
5.3.1 Europe Herceptin Biosimilar Market Overview
5.3.2 Europe 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.3.4 Europe 2016 Herceptin Biosimilar Market Share Analysis
5.4 Southeast Asia Herceptin Biosimilar Market Analysis
5.4.1 Southeast Asia Herceptin Biosimilar Market Overview
5.4.2 Southeast Asia 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.4.4 Southeast Asia 2016 Herceptin Biosimilar Market Share Analysis
5.5 Japan Herceptin Biosimilar Market Analysis
5.5.1 Japan Herceptin Biosimilar Market Overview
5.5.2 Japan 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.5.4 Japan 2016 Herceptin Biosimilar Market Share Analysis
5.6 India Herceptin Biosimilar Market Analysis
5.6.1 India Herceptin Biosimilar Market Overview
5.6.2 India 2012-2017E Herceptin Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Herceptin Biosimilar Sales Price Analysis
5.6.4 India 2016 Herceptin Biosimilar Market Share Analysis
6 Global 2012-2017E Herceptin Biosimilar Segment Market Analysis (by Type)
6.1 Global 2012-2017E Herceptin Biosimilar Sales by Type
6.2 Different Types of Herceptin Biosimilar Product Interview Price Analysis
6.3 Different Types of Herceptin Biosimilar Product Driving Factors Analysis
6.3.1 Capsule of Herceptin Biosimilar Growth Driving Factor Analysis
6.3.2 Tablet of Herceptin Biosimilar Growth Driving Factor Analysis
6.3.3 Others of Herceptin Biosimilar Growth Driving Factor Analysis
7 Global 2012-2017E Herceptin Biosimilar Segment Market Analysis (by Application)
7.1 Global 2012-2017E Herceptin Biosimilar Consumption by Application
7.2 Different Application of Herceptin Biosimilar Product Interview Price Analysis
7.3 Different Application of Herceptin Biosimilar Product Driving Factors Analysis
7.3.1 Healthcare&Pharmaceuticals of Herceptin Biosimilar Growth Driving Factor Analysis
7.3.2 Others of Herceptin Biosimilar Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Herceptin Biosimilar
8.1 Mylan
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Mylan 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Mylan 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Amgen 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.3 Mabion
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Mabion 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Mabion 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.4 AryoGen Biopharma
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 AryoGen Biopharma 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 AryoGen Biopharma 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.5 Genor Biopharma
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Genor Biopharma 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Genor Biopharma 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.6 The Instituto Vital Brazil
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 The Instituto Vital Brazil 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 The Instituto Vital Brazil 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.7 Celltrion
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Celltrion 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Celltrion 2016 Herceptin Biosimilar Business Region Distribution Analysis
8.8 Gedeon Richter
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Gedeon Richter 2016 Herceptin Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Gedeon Richter 2016 Herceptin Biosimilar Business Region Distribution Analysis
9 Development Trend of Analysis of Herceptin Biosimilar Market
9.1 Global Herceptin Biosimilar Market Trend Analysis
9.1.1 Global 2017-2022 Herceptin Biosimilar Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Herceptin Biosimilar Sales Price Forecast
9.2 Herceptin Biosimilar Regional Market Trend
9.2.1 North America 2017-2022 Herceptin Biosimilar Consumption Forecast
9.2.2 China 2017-2022 Herceptin Biosimilar Consumption Forecast
9.2.3 Europe 2017-2022 Herceptin Biosimilar Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Herceptin Biosimilar Consumption Forecast
9.2.5 Japan 2017-2022 Herceptin Biosimilar Consumption Forecast
9.2.6 India 2017-2022 Herceptin Biosimilar Consumption Forecast
9.3 Herceptin Biosimilar Market Trend (Product Type)
9.4 Herceptin Biosimilar Market Trend (Application)
10 Herceptin Biosimilar Marketing Type Analysis
10.1 Herceptin Biosimilar Regional Marketing Type Analysis
10.2 Herceptin Biosimilar International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Herceptin Biosimilar by Region
10.4 Herceptin Biosimilar Supply Chain Analysis
11 Consumers Analysis of Herceptin Biosimilar
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Herceptin Biosimilar Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Herceptin Biosimilar
Table Product Specifications of Herceptin Biosimilar
Table Classification of Herceptin Biosimilar
Figure Global Production Market Share of Herceptin Biosimilar by Type in 2016
Figure Capsule Picture
Table Major Manufacturers of Capsule
Figure Tablet Picture
Table Major Manufacturers of Tablet
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Herceptin Biosimilar
Figure Global Consumption Volume Market Share of Herceptin Biosimilar by Application in 2016
Figure Healthcare&Pharmaceuticals Examples
Table Major Consumers in Healthcare&Pharmaceuticals
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Herceptin Biosimilar by Regions
Figure North America Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Figure China Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Figure Europe Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Figure Southeast Asia Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Figure Japan Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Figure India Herceptin Biosimilar Market Size (Million USD) (2012-2022)
Table Herceptin Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Herceptin Biosimilar in 2016
Figure Manufacturing Process Analysis of Herceptin Biosimilar
Figure Industry Chain Structure of Herceptin Biosimilar
Table Capacity and Commercial Production Date of Global Herceptin Biosimilar Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Herceptin Biosimilar Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Herceptin Biosimilar Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Herceptin Biosimilar Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Herceptin Biosimilar 2012-2017
Figure Global 2012-2017E Herceptin Biosimilar Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Herceptin Biosimilar Market Size (Value) and Growth Rate
Table 2012-2017E Global Herceptin Biosimilar Capacity and Growth Rate
Table 2016 Global Herceptin Biosimilar Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Herceptin Biosimilar Sales (K MT) and Growth Rate
Table 2016 Global Herceptin Biosimilar Sales (K MT) List (Company Segment)
Table 2012-2017E Global Herceptin Biosimilar Sales Price (USD/MT)
Table 2016 Global Herceptin Biosimilar Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure North America 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure North America 2016 Herceptin Biosimilar Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure China 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure China 2016 Herceptin Biosimilar Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure Europe 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure Europe 2016 Herceptin Biosimilar Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure Southeast Asia 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure Southeast Asia 2016 Herceptin Biosimilar Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure Japan 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure Japan 2016 Herceptin Biosimilar Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Herceptin Biosimilar 2012-2017E
Figure India 2012-2017E Herceptin Biosimilar Sales Price (USD/MT)
Figure India 2016 Herceptin Biosimilar Sales Market Share
Table Global 2012-2017E Herceptin Biosimilar Sales (K MT) by Type
Table Different Types Herceptin Biosimilar Product Interview Price
Table Global 2012-2017E Herceptin Biosimilar Sales (K MT) by Application
Table Different Application Herceptin Biosimilar Product Interview Price
Table Mylan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Mylan Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Mylan Herceptin Biosimilar Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Amgen Herceptin Biosimilar Business Region Distribution
Table Mabion Information List
Table Product A Overview
Table Product B Overview
Table 2015 Mabion Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Mabion Herceptin Biosimilar Business Region Distribution
Table AryoGen Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 AryoGen Biopharma Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 AryoGen Biopharma Herceptin Biosimilar Business Region Distribution
Table Genor Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Genor Biopharma Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Genor Biopharma Herceptin Biosimilar Business Region Distribution
Table The Instituto Vital Brazil Information List
Table Product A Overview
Table Product B Overview
Table 2016 The Instituto Vital Brazil Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 The Instituto Vital Brazil Herceptin Biosimilar Business Region Distribution
Table Celltrion Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celltrion Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Celltrion Herceptin Biosimilar Business Region Distribution
Table Gedeon Richter Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gedeon Richter Herceptin Biosimilar Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Gedeon Richter Herceptin Biosimilar Business Region Distribution
Figure Global 2017-2022 Herceptin Biosimilar Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Herceptin Biosimilar Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Herceptin Biosimilar Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Herceptin Biosimilar Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Herceptin Biosimilar by Type 2017-2022
Table Global Consumption Volume (K MT) of Herceptin Biosimilar by Application 2017-2022
Table Traders or Distributors with Contact Information of Herceptin Biosimilar by Region
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
